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ABSTRACT 
 
Background: Dengue Hemorrhagic Fever (DHF) has a high cost burden. Payment for hospital 
treatment was paid by Health insurance (BPJS) with a case based payment method in the era of the 
National Health Insurance. This method allowed the hospital to gain profit or loss. This study 
aimed to analyze the factors that influence the differences in Indonesian Cased Based Groups (INA 
CBGs) with the medical service costs for DHF in Dr. Soeroto hospitals, Ngawi Regency. 
Subjects and Method: This study used an observational analytic study with a cross-sectional approach 
conducted at Dr. Soeroto Hospital, Ngawi Regency, East Java in September - October 2019. A sample of 200 
subjects was selected by using simple random sampling. The dependent variable was the difference in rate. 
The independent variables were class of care, length of stay, age, blood transfusion, comorbidity and 
complications. Data analysis was using multiple linear regression with Stata 13. 
Results: INA CBG rates (mean= Rp 6,120,000; SD= Rp 2,330,000) was lower than the cost of 
hospital treatment (mean= Rp 7,070,000; SD= Rp 4,650,000). There is a negative relationship 
between the difference in rates and it was statistically significant on the length of stay (b= 0.73; 
95% CI= -1,131,915 to -329,501; p= <0.001), patients’ age (b= 0.41; 95% CI= -707,099 to -110,293; 
p= 0.008), blood transfusion action (b= 0.79; 95% CI= -1,549,446 to -34,190; p= 0.041), and 
comorbidity (b= 1.14 ; 95% CI= -1,817,112 to -474,641; p= 0.001). While there was a statistically 
insignificant relationship between classes of care (b= 0.42; 95% CI = -931,443 to 82,607; p= 0.100) 
and complication (b= 0.34; 95% CI= -1,093,208 to 408,223; p= 0.369).  
Conclusion: Difference in INA CBG rates and hospital medical service costs were affected by the 
class of care, length of stay, age, blood transfusion, comorbidity and complications. 
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BACKGROUND 
Dengue Haemorrhagic Fever (DHF) is one 
of the diseases caused by Aedes aegypti and 
Aedes albopictus species. DHF is one of the 
public health problems in Indonesia where 
the number of sufferers is increasing and its 
spread is getting wider. The number of DHF 
cases in Indonesia until 3rd of February 
2019 was 16,692 cases with 169 mortality. 
Director General of Disease Prevention and 
Control, Ministry of Health Republic of 
Indonesia Dr. Anung Sugihantono, M. Kes 
reported that East Java still has the highest 
number of cases (Ministry of Health Re-
public of Indonesia, 2019). Ngawi Regency, 
East Java, reported DHF cases in January 
by 483 cases of dengue fever, in February 
there were 252 cases, in March there were 
189 cases, in April were 80 cases and six 
residents of Ngawi District were declared 
dead due to DHF (Rasi, 2019).  
DHF has a significant cost burden for 
the Indonesian people. The total cost of 
dengue fever in Indonesia in 2015 is esti-
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mated to reach 5.64 T consisting of 5.25 T 
for inpatient care and 387.81 M for outpati-
ent cases (Id et al., 2019). Health care costs 
are directly taken from the fee for service 
system or patients pay health care costs 
after getting health care and INA CBGs pay-
ment methods paid by Health insurance 
with payment claims. 
The Social Security Organizing Agency 
(BPJS) is a body that organizes the National 
Health Insurance (JKN) for the achievement 
of Universal Health Coverage (UHC). The 
administration of JKN by BPJS is regulated 
in Law Number 24 of 2014. BPJS Health 
plays a role in collecting health care 
financing in primary and advanced health 
care providers. Funding by BPJS at 
hospitals based on Indonesia Case based 
Groups (INA CBGs) rates. The INA CBGs 
payment pattern is a prospective payment 
method, which is a health service rate that 
has been determined before health services 
are provided. The health services provided 
include medical and non-medical services 
both outpatient and inpatient services 
whose service rates have been determined in 
Minister of Health Regulation No. 76 of 
2016 (Ministry of Health of the Republic of 
Indonesia, 2016). 
The largest proportion of hospitals 
cooperating with Health BPJS is private 
hospitals at 60.45%, followed by regional 
government hospitals at 31.04% and central 
government hospitals at 8.51% (BPJS, 
2017). Therefore, the hospital has many 
competitors. In addition, this also implies 
that hospitals are required to be more 
efficient and effective in providing medical 
services to patients so that they survive in 
the era of competition between hospital 
services and the current JKN era. 
Within the five years of JKN, there 
have been various opinions which state that 
medical services with INA CBG rates are 
judged to have differences with hospital 
medical service tariffs. Research done by 
Rahayuningrum et al. (2016) said similar 
things that the average hospital inpatient 
costs were lower than the average INA CBG 
rates. Mardhatillah et al. (2017) also stated 
that the mean of INA CBG reimbursement 
in hospitalization for chronic kidney disease 
was lower than the mean of hospital medical 
care costs. Hospitals that can reduce pro-
duction costs for certain diagnostic group 
medical services so that the average unit 
cost per patient is lower than the INA CBGs 
rates can get benefit from the health services 
provided. Conversely, if the unit cost per 
patient is higher than the INA CBG rate, the 
hospital will experience losses.  
Based on this background, it is 
important to examine whether there are 
differences in the actual average cost of 
hospitalization in hospitals and inpatient 
rates determined by Health BPJS. It is also 
important to examine the factors that 
influence these differences. 
 
SUBJECTS AND METHOD 
1. Study Design  
This study was a quantitative study using 
observational analytic studies with cross-
sectional approaches conducted at the Dr. 
Soeroto Hospital in Ngawi District, East 
Java in September - October 2019. 
2. Population and Sample 
This study used a population of inpatients 
JKN participants with Dengue Hemorrhagic 
Fever (DHF) in Dr. Soeroto Hospital in 
Ngawi Regency in July 2018 - July 2019. 
The researchers used the simple random 
sampling method in the selection of 200 
sample subjects. 
3. Study Variables 
The dependent variable was the difference 
between the INA CBGs and the hospital 
inpatient service costs. The independent 
variables were the type of class, length of 
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stay, age, blood transfusion, comorbidity, 
and complications. 
4. Operational Definition of Variables 
Type of Care was a classification of in-
patient classes for DHF patients at Dr. 
Soeroto Hospital, Ngawi Regency. The data 
were collected by questionnaire. The measu-
rement scale was categorical, coded 0 for 
class 1 and 1 for class 2 and 3. 
Length of Stay was the inpatient time of 
DHF patients in the day at Dr. Soeroto 
Hospital, Ngawi Regency. The data were 
obtained from medical record. The measu-
rement scale was continuous, but it was 
transformed into dichotomous, coded 0 for 
<4 days and 1 for ≥4 days. 
Age was the age of inpatient DHF patients 
in years when getting treatment at Dr. 
Soeroto Hospital, Ngawi Regency. The data 
were collected by questionnaire. The measu-
rement scale was continuous, but it was 
transformed into dichotomous, coded 0 for 
<14 years and 1 for ≥14 years. 
Blood transfusion was a supporting me-
dical procedure in the form of blood trans-
fusion obtained by inpatient DHF patients 
at Dr. Soeroto Hospital, Ngawi Regency. The 
data were obtained from medical record. 
The measurement scale was categorical, 
coded 0 for no and 1 for yes. 
Comordibity was a disease that accompa-
nies the main diagnosis of DHF inpatients in 
Dr. Soeroto Hospital, Ngawi Regency. The 
data were obtained from medical record. 
The measurement scale was categorical, 
coded 0 for no and 1 for yes. 
Complication was a disease that arises 
during the treatment of DHF patients in Dr. 
Soeroto Hospital, Ngawi Regency. The data 
were obtained from medical record. The 
measurement scale was categorical, coded 0 
for no and 1 for yes. 
5. Data Analysis 
Univariate analysis explained the general 
description of research data with each study 
variable presented in n, percentage, mean, 
standard deviation (SD), minimum, and 
maximum. Bivariate analysis explained the 
relationship of one independent variable to 
one dependent variable by using the Pea-
rson correlation. Multivariate analysis 
explained the relationship of more than one 
independent variable by using the multiple 
linear regression test on Stata 13. 
6. Research Ethics 
The study protocol was approved by the 
Medical Research Ethics Committee of Dr. 
Moewardi Regional General Hospital Sura-
karta with number: 1.080/XI/HREC/2019. 
 
RESULTS 
1. Sample Characteristics 
The highest proportion of study subjects 
were 110 women (55%) and the highest age 
range was ≥14 years old, namely 130 people 
(65%) which can be seen in table 1. 
2. Univariate Analysis  
Table 2 showed that class 3 was the most 
care for 147 (73.5%). Blood transfusion was 
carried out only on 11 persons (5.5%) with 
27 patients (13.5%) experiencing comorbidi-
ties and 15 complications (7.5%). 
Table 3 showed that the mean INA 
CBG rates were smaller than the mean me-
dical service costs at Dr. Soeroto Hospital, 
Ngawi Regency with a difference of -0.45 or 
minus Rp 450,000. The minimum value of 
the difference between the bases of -10.71 or 
minus Rp 10,710,000 and a maximum value 
of 0.97 or Rp. 970,000. The duration of 
treatment was 1-9 days with an average stay 
of 5 days. Patients aged between 1-70 years 
old with an average age of 22 years old. The 
lowest standard deviation was the difference 
in rates. 
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Table 1. Sample Characteristics  
Characteristics 
Cases 
N % 
a. Gender 
Male  90 45 
Female  110 55 
b. Age (years old) 
< 14 years old 70 35 
≥ 14 years old 130 65 
n observation = 200 
 
Table 2. The description of study variable 
Variables n % 
1. Class of Treatment 
Class 1 16 8 
Class 2 37 18.5 
Class 3 147 73.5 
2. Blood transfusion 
Yes 11 5.5 
No  189 94.5 
3. Complication 
Yes 15 7.5 
No  185 92.5 
4. Comorbidity 
Yes 27 13.5 
No  173 86.5 
Table 3. The description of study variable 
Variables N Mean SD Min. Max. 
INA CBGs Costs (x Rp 1,000,000) 200 1.68 2.93 1.51 3.18 
Hospital service Costs (x Rp 1,000,000) 200 2.13 1.34 0.54 13.44 
Costs difference (x Rp 1,000,000) 200 -0.45 1.23 -10.71 0.97 
Length of treatment (days) 200 4.88 1.46 1 12 
Age (years old) 200 21.79 14.51 1 70 
 
3. Bivariate Analysis  
Table 4 showed that there was a statistically 
significant relationship between the diffe-
rence in costs with INA CBG costs (r= -0.28; 
p= 0.0001), hospital medical service costs 
(r= -0.97; p<0.001), length of stay (r= -0.57; 
p<0.001), age (r= -0.26; p= 0.002), blood 
transfusion (r= -0.41; p<0.001), comorbi-
dity (r= -0.52; p<0.001), complication (r= -
0.41; p<0.001). 
4. Multivariate Analysis  
Table 5 showed that there was a negative 
relationship and it was statistically signifi-
cant between the difference in the rates of 
hospitalization for DHF cases in hospitals 
and inpatients for ≥4 days (b= 7.31; 95%= -
1,131,915 to -329,501; p<0.001), age ≥14 
years old (b= 4.09; 95% CI= -707,099 to -
110,293;  p= 0.008), blood transfusion act-
ion (b= 7.92; 95% CI= -1,549,446 to -
34,190; p= 0.041), and DHF patient’s 
comorbidity (b= 11.45; 95% CI= -1,817,112 to 
-474,641;  p= 0.001).  There was a negative 
relationship between the difference in hos-
pitalization rates for DHF cases in hospitals 
with the type of class (b= 4.24; 95% CI = -
931,443 to 82,607; p= 0.100) and 
complication (b= 3.42; 95% CI= -1,093,208 
to 408,223; p= 0.369). 
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Table 4. The results of the bivariate analysis of the relationship between the 
difference in rates and a number of variables 
Variables r p 
INA CBGs Costs (x Rp 1000,000) -0.28 0.0001 
Hospital service Costs (x Rp 1000,000) -0.97 <0.001 
Inpatient classes (class 2 and 3) -0.11 0.1273 
Length of stay (≥4 days) -0.57 <0.001 
Age (≥14 years old) -0.26 0.0002 
Blood transfusion (yes) -0.41 <0.001 
Comorbidity (yes) -0.52 <0.001 
Complication (yes) -0.41 <0.001 
n observation = 200   
 
Table 5. The results of the multiple linear regression analysis about the rela-
tionship between the difference in INA CBG costs and the cost of hospitalization 
for DHF and the factors that influence them 
Independent Variable b 
95% CI p 
Lower limit Upper limit 
Constants 1161748 565,568 1,757,927 <0.001 
Inpatient classes (class 2,3) -424,418 -931,443 82,607 0.100 
Length of stay (days) -730,708 -1,131,915 -329,501 <0.001 
Age (years old) -408,696 -707,099 -110,293 0.008 
Blood transfusion (yes) -791,818 -1,549,446 -34,190 0.041 
Complication (yes) -342,492 -1,093,208 408,223 0.369 
Comorbidity (yes) -1,145,877 -1,817,112 -474,641 0.001 
n observation = 200 
Adjusted R2 = 36.4% 
p= 0.050 
    
 
DISCUSSION 
1. INA CBG costs compared to the 
costs of inpatient medical services 
in DHF cases 
The results of the analysis showed that INA 
CBG costs for inpatient DHF cases were 
lower than the cost of medical services at Dr. 
Soeroto Hospital, Ngawi Regency was 
shown with a negative and statistically signi-
ficant relationship. Therefore, it was stated 
that the hospital suffered losses. Mardha-
tillah et al. (2017) showed a similar study 
result that there was a difference between 
the costs of INA CBGs and the costs of 
inpatient services in hospitals in cases of 
chronic kidney disease. Wulandari et al. 
(2019) also showed the results of study on 
differences in INA CBGs costs and hospital 
costs in stroke cases.  
Determination of hospital medical ser-
vice costs was an important aspect in the era 
of national health insurance. Local govern-
ments played an important role in deter-
mining hospital medical service rates for 
government-owned hospitals that have im-
plemented financial management of region-
al public service agencies. The hospital cost 
was in accordance with the provisions of the 
Minister of Health Regulation of the Repu-
blic of Indonesia number 85 of 2015 con-
cerning national hospital cost patterns 
(Ministry of Health of the Republic of 
Indonesia, 2015).  
The application of INA CBG costs as a 
payment method made the hospitals to 
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calculate the cost of medical services both 
outpatient and inpatient more carefully to 
achieve maximum efficiency and cost effec-
tiveness in the use of hospital resources. 
Payment of INA CBGs claims was expected 
to provide benefits in facilitating revenue 
calculations for hospitals. But the results of 
this study showed the opposite.  
The results of the analysis found that 
the rate of INA CBGs was lower than the 
cost of medical services in the case of DHF 
inpatient in Dr. Soeroto Hospital, Ngawi 
Regency, so that the hospital suffered losses. 
Conversely, if the INA CBG rate was higher 
than the cost of medical services at the 
hospital, the hospital would get the benefit. 
Therefore, hospitals must be careful in 
calculating the cost of medical services in 
order to maintain their survival through 
surpluses or profits without ignoring the 
social functions of the hospital (Hidayat et 
al., 2016). 
2. The relationship between age and 
the difference in costs between INA 
CBGs and the cost of hospital 
medical services 
The results of this study indicated that the 
largest population of 200 patient samples 
was over 14 years old. The results of the data 
analysis showed that there was a negative 
relationship between the patient's age and 
the difference in INA CBG cost and medical 
services for DHF inpatient at Dr. Soeroto 
hospitals. This was similar to research con-
ducted by Thai et al., (2011) which showed 
that older DHF patients were more likely to 
develop DHF symptoms from a younger age 
for primary and secondary infections, the 
proportion of patients with symptoms 
symptomatic among total infected indivi-
duals were <7% in patients aged less than 10 
years old, and reach 8 - 11% at age 20 years 
old.   
Age was an important modulator in 
DHF case. Recently, DHF cases were incre-
asing in the state of Southeast Asia, an 
increase in adult patients due to a decrease 
in the strength of infection which can be 
caused by various factors including varia-
tions in epidemiological, ecological and 
demographic dynamics (Thai et al., 2011). 
DHF in adult patients was increasingly 
important but was very poorly studied. 
Atypical clinical manifestations, made the 
diagnosis and management of adult patients 
with DHF more challenging. There was an 
urgent need to improve current diagnostic 
criteria, classify disease severity and identify 
individual complications (Lin et al., 2017). 
 Hospitals need management strate-
gies to overcome this issue because of the 
increased number of morbidity among adult 
DHF patients. 
3. The relationship between class of 
treatment and the difference in 
costs between INA CBGs and the 
cost of hospital medical services 
The results showed that the largest popu-
lation of 200 patient samples using class 3 
treatments were 147 patients, followed by 
class 2 treatments which were 37 patients 
and class 1 treatment were 16 patients. The 
results of data analysis showed that there 
was a negative relationship between the 
class of DHF patient care with the difference 
in INA CBG rates and the cost of inpatient 
DHF medical care at Dr. Soeroto Hospital. 
However, the relationship was not signifi-
cant. Rahayuningrum et al. (2016) stated 
that between the class of care with the diffe-
rence in INA CBG rates and hospital rates, 
there was a statistically insignificant rela-
tionship. The study showed that the average 
of patient chose class 3. Various hospitals in 
Indonesia have more class 3 treatment 
rooms than other treatment classes.  
Minister of Health Regulation No. 64 
of 2016 concerning Health Service Cost 
Standards in the Implementation of the 
Health Insurance Program has set rates 
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based on care classes including class 1, class 
2, and class 3 (Ministry of Health, Republic 
of Indonesia, 2016). Therefore, there were 
differences in rates in each treatment class. 
The higher the class of care, the greater the 
nominal rate of INA CBGs in rupiah. This 
was in line with the inpatient room rates at 
the hospital, the higher the class of treat-
ment, the higher the inpatient room rates. It 
was also based on the completeness of the 
facilities, comfort and privacy that was 
provided by the hospital to patients during 
their stay. 
4. The relationship between length of 
stay and the difference in costs 
between INA CBGs and the cost of 
hospital medical services  
The results showed the largest population of 
200 patient samples received inpatient me-
dical services for DHF cases for 12 days of 
treatment. The analysis showed that there 
was a negative relationship between the 
length of stay of patients with DHF cases 
and the difference in INA CBG rates and the 
cost of inpatient DHF medical care at Dr. 
Soeroto Hospital, and the relationship was 
not significant. Mardhatillah et al. (2017) 
and Wulandari et al. (2019) showed similar 
study results that were statistically signifi-
cant relationship between length of stay 
with INA CBG rates and the cost of inpatient 
medical care for DHF cases. Length of Stay 
(LOS) or length of treatment was very indi-
vidual and was influenced by the case or 
diagnosis of the disease and its prognosis 
(Almashrafi et al., 2016). The longer the 
LOS, the higher the operational costs 
incurred by the hospital, even though the 
INA CBG rates were permanent. 
Vo et al. (2017) stated that the cost of 
hospitalization for DHF cases in Vietnam 
was increased from US $ 3,700 in 2013 to 
US $ 5,500 in 2014 and exceeded US $ 
10,000 in 2015. In 2013, the cost of hospital 
admission per day was 17.9% of direct 
medical costs, and contributed 27.8% of 
direct medical costs in 2015. Pham et al. 
(2016) stated that 50.2% of the total cost of 
DHF cases in hospitals was inpatient costs. 
5. The relationship between blood 
transfusion action and the diffe-
rence in costs between INA CBGs 
and the cost of hospital medical 
services  
The results showed the largest population of 
200 samples of patients who received blood 
transfusion were 11 inpatients with DHF 
cases. The results of the data analysis 
showed that there was a negative relation-
ship between the blood transfusion action of 
DHF patients with the difference in INA 
CBG rates and the cost of medical care for 
DHF inpatient at Dr. Soeroto Hospital and 
the relationship was significant. Panmei et 
al. (2019) stated that only 14% of children 
DHF patients and 20% of adults patients 
with DHF needed blood transfusions in 
hospitals. 
According to WHO data in 2015, 
health services for DHF cases contributed a 
significant cost burden. The annual econo-
mic burden of controlling DHF in Southeast 
Asia during the decade of 2001 - 2010 was 
US $ 950,000,000 (US $ 610,000,000 to 
US $ 1,384,000,000) or around US $ 1.65 
per capita (US $ 1.06 to US $ 2.41) (Shepard 
et al., 2013). DHF also has a significant cost 
burden for the people of Indonesia. The 
total DHF cost burden in Indonesia in 2015 
was estimated to reach 5.64 T consisting of 
5.25 T for inpatient care and 387.81 M for 
outpatient cases (Id et al., 2019). 
6. The relationship between comorbi-
dity and the difference in costs 
between INA CBGs and the cost of 
hospital medical services  
The results showed that the largest popu-
lation of 200 samples of patients suffering 
from DHF accompanied by comorbidities of 
27 inpatients with DHF cases. The results of 
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the data analysis showed that there was a 
negative relationship between the patients 
comorbidity with DHF cases and the diffe-
rence in INA CBG rates and the cost of me-
dical care for DHF inpatient at Dr. Soeroto 
Hospital and the relationship was signifi-
cant. Aljunid and Jadoo (2018) stated that a 
longer hospital stay accompanied by major 
complications and comorbidities have the 
greatest influence on the total inpatient 
pharmacy cost. Some of the variability in 
costs seemed obvious, if patients have com-
plications, they would stay in the hospital 
longer or for comorbidities with higher costs 
of care. Nelson et al. (2016) stated that pati-
ents with greater comorbidities had higher 
hospital costs of $ 2,000.  
Pooransingh et al. (2016) stated that 
comorbidities that occurred in patients with 
DHF were caused by comorbidities such as 
diabetes and hypertension. This was also 
similar to the DHF case in Dr. Soeroto Hos-
pital, Ngawi Regency which found that dia-
betes was a accompanying disease of DHF 
patients. Tran et al. (2018) stated that DHF 
hospitalized patients with comorbidities and 
who experienced a longer duration of ill-
ness, had higher hospital medical service 
costs. 
7. The relationship between complica-
tion and the difference in costs 
between INA CBGs and the cost of 
hospital medical services  
The results showed the largest population of 
200 samples of patients suffering from DHF 
accompanied by complications of 15 inpati-
ents with DHF cases. The results of the data 
analysis showed that there was a negative 
relationship between the complications of 
DHF patients and the difference in INA CBG 
rates and the cost of medical care for DHF 
inpatient at Dr. Soeroto Hospital, but the 
relationship was not significant. Research in 
Malaysia done by Aljunid and Jadoo (2018) 
showed that longer period of hospitalization 
accompanied by complication has the great-
est effect on the total inpatient pharmacy 
cost. Patients with conditions such as dia-
betes mellitus, pregnancy, obesity, kidney 
failure, elderly, and chronic hemolytic ane-
mia have a higher risk of DHF complica-
tions. This group of patients needed to be 
admitted to the hospital for observation. 
Procedures for actions for high morbidity, 
reducing complications, and reducing length 
of stay can help hospitals to deal with ever-
increasing financial pressures while im-
proving the quality of care. 
In conclusion, Dr. Soeroto Hospital in 
Ngawi regency provided additional money 
to cover the difference in cost with INA-CBG 
cost. Factors related to fare differences were 
length of stay, age, blood transfusion and 
comorbidity. The authors suggested the 
hospitals to improve the quality of medical 
services to reduce patient's comorbidity so 
that it can reduce patient's length of stay. 
This was an attempt by the hospital to 
minimize the financial deficit of DHF 
patients. 
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